Board of Directors

2024 - 2025

President

Abdulmaged M. Traish, MBA, PhD
Boston University - School of Medicine
1 Harrington Rd.
Winchester, MA 01890

Abdulmaged Traish earned a B.Sc., in Chemistry & Botany form the University of Tripoli, Tripoli, LIBYA in 1971 and a Ph.D., in Biochemistry from Boston University, Boston, MA in January of 1978. After two years of training as a postdoctoral Fellowship in the Department of Biochemistry at Boston University school of Medicine, he was appointed as an assistant research professor of Biochemistry. Professor Traish also earned Master of Business Administration (MBA) from Boston University School of Management in 1993. Since 1979, Dr. Traish was collaborating with faculty in the Urology Department and in 1996 he was promoted to full professor in the Department of Biochemistry and Department of Urology. Research Professor Traish pursued basic research, in the field of steroid biochemistry and physiology of reproductive and sexual medicine. His contributions to the field of sexual medicine include the development of experimental animal models to investigate the endocrine regulation of sexual arousal physiology and function in males and females and his pioneering work on the basic mechanisms of sex steroid hormones on erectile physiology. Professor Traish has been successful in procuring research funds from the National Institute of Health as well as from the Private Sector and was instrumental in the establishment of the institute for sexual medicine at Boston University school of Medicine. Dr. Traish is a researcher with renowned national and international reputation.

Vice President

Martin Miner, MD
Men's Health Center
180 Collier St 2nd Floor
Providence, RI 02906

Dr. Martin Miner is the founder and co-director of the Men’s Health Center at the Miriam Hospital in Providence, Rhode Island. He served as Chief of Family and Community Medicine for the Miriam Hospital, a teaching hospital of the Warren Alpert Medical School, from 2008 to 2018. The Men’s Health Center, under his leadership, was the first such center to open in the US. He is a clinical professor of family medicine and urology at the Warren Alpert Medical School of Brown University in Providence and has been charged with the development of a multidisciplinary Men’s Health Center within the Lifespan/Brown University system since 2008.

Secretary

Sandeep Dhindsa, MD
Saint Louis University, SLUCare Academic Pavilion
1008 South Spring Street
2nd Floor, Room# 2525
Saint Louis, MO 63110

Dr. Sandeep Dhindsa is Professor of Medicine (with tenure) and Chief of the Division of Endocrinology and Metabolism at Saint Louis University. He completed his medical schooling from All India Institute of Medical Sciences in New Delhi, India. He did residency in Internal medicine from State University of New York at Brooklyn and fellowship in Endocrinology from University at Buffalo, NY.

His primary area of research is hypogonadism in men with obesity and diabetes. He has served as the primary investigator on a grant from the American Diabetes Association and co-investigator on a grant from NIH to elucidate the effects of hypogonadism in men with type 2 diabetes or obesity on insulin sensitivity and inflammation and the response to treatment with testosterone.

Treasurer

Michael Zitzmann, MD, PhD
University Muenster
Clinical Andrology
Domagkstrasse 11
D-48149 Muenster
GERMANY

Professor Michael Zitzmann is specialised within the fields of andrology, endocrinology, diabetology and sexual medicine at the University Clinics of Muenster, Germany.

Regarding patient care, he focusses on endocrinological andrology and patients with sexual disorders: boys with pubertal disorders up to aging men with a variety of sexual and metabolic problems seek his advice.

Since more than 25 years, his research also focusses on the development of contraceptives for men. Since then, he continues to perform as principal investigator in many international  studies, collaborating with WHO and other organisations. Michael Zitzmann is a member of international committees, journal editorial boards and is on the Educational Board of the European Association of Andrology (EAA) and the German Adiposity Foundation. He is on the Board of the European Society of Sexual Medicine (ESSM) and holds the status of a Fellow of the European Committee of Sexual Medicine (FECSM). Michael Zitzmann is Editor in Chief of the journal The Aging Male and is on the Board of the US-American Androgen Society.

 

Immediate Past President

Hugh Jones, BSc, MBChB, MD, FRCP
Robert Hague Centre for Diabetes and Endocrinology
Barnsley Hospital
Gawber Road
S75 2 EP
Barnsley
UNITED KINGDOM

Professor Thomas Hugh Jones is a Physician with a special interest in Diabetes and Endocrinology at Barnsley Hospital and a Professor of Andrology at the University of Sheffield Medical School, Sheffield, UK. He also has a degree in Biochemistry. His research is both laboratory and clinically based.

He has a major research interest in the role of Testosterone in the pathogenesis and treatment of men with cardiovascular disease and with Tyoe 2 Diabetes. He was first to discover that testosterone therapy improves insulin resistance the central biochemical defect in Type 2 Diabetes. 

Executive Secretary

Abraham Morgentaler, MD, FACS
Men's Health Boston
540 N. Tamiami Trail, Ste #1501
Sarasota, FL 34236

Abraham Morgentaler, MD was born in Montreal, Canada.  He graduated from Harvard College in 1978, and Harvard Medical School in 1982.  Dr. Morgentaler completed his residency in 1988 from the Harvard Program in Urology, and then joined the faculty of Beth Israel Deaconess Medical Center and Harvard Medical School.  He is currently the Blavatnik Faculty Fellow in Health and Longevity at Harvard Medical School. 

Dr. Morgentaler is an international authority on men’s health and a pioneer in the treatment of testosterone deficiency in men.  His research is credited for reversing the decades-old belief that testosterone therapy is risky for prostate cancer.  Dr. Morgentaler has published over 200 scientific articles on testosterone, prostate cancer, male sexual dysfunction, and male infertility. His h-index is 60.   

Members-at-Large

Adrian S. Dobs, MD, MHS
Johns Hopkins University
1830 East Monument Street
Suite 328
Baltimore, MD 21287

Adrian Sandra Dobs, MD, MHS, is Professor of Medicine and Oncology and Director of the Johns Hopkins Clinical Research Network of the Johns Hopkins Institute for Clinical and Translational Research (JHCRN). The JHCRN is a multi-institutional collaboration linking academic and community hospitals in the mid-Atlantic United States.

Dr Dobs received her undergraduate degree from Cornell University, a medical degree from Albany Medical College, in New York, and completed an internship in internal medicine at Montefiore Hospital, Albert Einstein College of Medicine, in the Bronx, New York. She held a fellowship in endocrinology from Johns Hopkins University School of Medicine and earned a master in health sciences degree in cardiovascular epidemiology at the Johns Hopkins University Bloomberg School of Public Health.

Members-at-Large

Geoffrey Hackett, MD
Good Hope Hospital Sutton Coldfield UK
Holly Cottage - Fisherwick Rd
Lichfield, Staffordshire WS14 9JL
UNITED KINGDOM

Professor Geoffrey Hackett was a consultant in Urology at University Hospitals Birmingham Foundation trust from 1994 – 2020 and Professor of Sexual Medicine at Aston University Birmingham since 2017. He worked as a Consultant in Urology and Sexual Medicine at Spire Hospital, Little Aston, Birmingham from 1998- 2024 and at Newson Health Menopause Clinic in Stratford-on Avon from 2016-2020..

 He was also as a primary care physician for 34 years from 1978-2012. Professor Hackett was Chairman of the British Society for Sexual Medicine from 2005–2007 and has been on the Scientific Committee of the European Society for Sexual Medicine (ESSM) from 2003–2009, Executive Committee of ESSM from 2015-2017 and  ISSM 2009-2012.

Mission

The mission of the Androgen Society is to promote excellence in research, education, and clinical practice regarding testosterone deficiency and its treatment.

Copyright © Androgen Society 2024 | Privacy Policy